{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "e9409999-854d-4eed-94a5-46309a0e330b",
   "metadata": {},
   "source": [
    "# SPTAN1 Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (SPG91)\n",
    "Deleterious variants in SPTAN1 are associated with several diseases including\n",
    "[Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia-OMIM:620538](https://omim.org/entry/620538)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "671de2dc-8c9f-473d-88d8-9aaa5bc7984b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Using pyphetools version 0.9.72\n"
     ]
    }
   ],
   "source": [
    "from pyphetools.creation import TemplateImporter\n",
    "from pyphetools.visualization import IndividualTable, QcVisualizer\n",
    "from IPython.display import display, HTML\n",
    "import pyphetools\n",
    "print(f\"Using pyphetools version {pyphetools.__version__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "08b81fb0-18e0-4af1-98b3-f1854c241fce",
   "metadata": {},
   "outputs": [],
   "source": [
    "template = \"input/SPTAN1_SPG91_individuals.xlsx\"\n",
    "hp_json = \"../hp.json\"\n",
    "created_by = \"0000-0002-0736-9199\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "304a4054-d6de-4d95-b246-adddb6a868cf",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HPO version 2024-03-06\n",
      "Created encoders for 35 fields\n",
      "Importing OMIM:620538, Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia, HGNC:11273, SPTAN1,  NM_001130438.3\n",
      "We output 28 GA4GH phenopackets to the directory phenopackets\n"
     ]
    }
   ],
   "source": [
    "timporter = TemplateImporter(template=template, hp_json=hp_json, created_by=created_by)\n",
    "individual_list, cvalidator = timporter.import_phenopackets_from_template()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "c05c9047-7297-49ae-a271-769948bb380c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<h2>Cohort validation</h2>\n",
       "<p>Errors found with 1 of 28 phenopackets.</p>\n",
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>Error counts</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Level</th><th style=\"text-align: left;font-weight: bold;\">Error category</th><th style=\"text-align: left;font-weight: bold;\">Count</th></tr>\n",
       "</table>\n",
       "<p>A total of 1 issues were fixed and no individual was removed from the cohort.</p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "qc = QcVisualizer(cohort_validator=cvalidator)\n",
    "display(HTML(qc.to_summary_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "3b13eb4b-c7f7-4920-b99c-7b16064732fc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>28 phenopackets - PMID:35150594 (n=22); PMID:36331550 (n=6)</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Individual</th><th style=\"text-align: left;font-weight: bold;\">Disease</th><th style=\"text-align: left;font-weight: bold;\">Genotype</th><th style=\"text-align: left;font-weight: bold;\">Phenotypic features</th></tr>\n",
       "<tr><td style=\"text-align: left;\">A:II:3 (MALE; P42Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.6247_6249del (heterozygous)</td><td style=\"text-align: left;\">Dystonia (HP:0001332); Ataxia (HP:0001251); Intellectual disability (HP:0001249); Myoclonus (HP:0001336); Paroxysmal dyskinesia (HP:0007166); excluded: Pes cavus (HP:0001761); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Abnormal pyramidal sign (HP:0007256); excluded: Microcephaly (HP:0000252); excluded: Spastic paraplegia (HP:0001258); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">B:II:1 (FEMALE; P28Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.6247_6249del (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Abnormal pyramidal sign (HP:0007256); Intellectual disability (HP:0001249); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Spastic paraplegia (HP:0001258); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">C:II:1 (MALE; P20Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.6247_6249del (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Intellectual disability (HP:0001249); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Abnormal pyramidal sign (HP:0007256); excluded: Microcephaly (HP:0000252); excluded: Spastic paraplegia (HP:0001258); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">D:II:2 (MALE; P36Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.6247_6249del (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Abnormal pyramidal sign (HP:0007256); Dysarthria (HP:0001260); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Spastic paraplegia (HP:0001258); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">E:II:1 (FEMALE; P15Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Pes cavus (HP:0001761); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">F:II:1 (FEMALE; P23Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Optic neuropathy (HP:0001138); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Distal lower limb muscle weakness (HP:0009053); Joint hypermobility (HP:0001382); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">G:II:1  (MALE; P28Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Optic neuropathy (HP:0001138); Pes cavus (HP:0001761); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">H:III:1 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Proximal muscle weakness in lower limbs (HP:0008994); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">I:I:1 (MALE; P57Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Peripheral axonal neuropathy (HP:0003477); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Distal lower limb muscle weakness (HP:0009053); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">I:II:1 (FEMALE; P15Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Seizure (HP:0001250); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Distal lower limb muscle weakness (HP:0009053); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">I:II:3 (MALE; P10Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">J:II:1 (FEMALE; P22Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Distal lower limb muscle weakness (HP:0009053); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">K:III:4 (FEMALE; P18Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Pes cavus (HP:0001761); Ataxia (HP:0001251); Peripheral axonal neuropathy (HP:0003477); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Distal lower limb muscle weakness (HP:0009053); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">K:III:5 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Pes cavus (HP:0001761); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Distal lower limb muscle weakness (HP:0009053); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">K:III:9 (FEMALE; n/a)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Peripheral axonal neuropathy (HP:0003477); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">K:IV:3 (MALE; P18Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Pes cavus (HP:0001761); Distal lower limb muscle weakness (HP:0009053); Peripheral axonal neuropathy (HP:0003477); Abnormal pyramidal sign (HP:0007256); Ataxia (HP:0001251); Spastic paraplegia (HP:0001258); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">K:IV:4 (MALE; P15Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Pes cavus (HP:0001761); Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); Proximal muscle weakness in lower limbs (HP:0008994); Distal lower limb muscle weakness (HP:0009053); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">K:IV:7 (MALE; n/a)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">K:IV:8 (FEMALE; n/a)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Abnormal pyramidal sign (HP:0007256); Spastic paraplegia (HP:0001258); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">L:II:1 (MALE; P15Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.3292C>T (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Seizure (HP:0001250); Abnormal pyramidal sign (HP:0007256); Intellectual disability (HP:0001249); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Spastic paraplegia (HP:0001258); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">M:II:1 (FEMALE; P34Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.4870C>T (heterozygous)</td><td style=\"text-align: left;\">Dystonia (HP:0001332); Ataxia (HP:0001251); Distal lower limb muscle weakness (HP:0009053); excluded: Pes cavus (HP:0001761); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Abnormal pyramidal sign (HP:0007256); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Spastic paraplegia (HP:0001258); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">N:II:1 (MALE; P26Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.6614A>C (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Seizure (HP:0001250); Abnormal pyramidal sign (HP:0007256); Intellectual disability (HP:0001249); Scoliosis (HP:0002650); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Spastic paraplegia (HP:0001258); excluded: Proximal muscle weakness in lower limbs (HP:0008994); excluded: Distal lower limb muscle weakness (HP:0009053); excluded: Dysarthria (HP:0001260)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 Patient 1 (FEMALE; P40Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Spastic gait (HP:0002064); Spastic paraplegia (HP:0001258); Lower limb muscle weakness (HP:0007340); Upper limb muscle weakness (HP:0003484); Babinski sign (HP:0003487); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Cerebellar atrophy (HP:0001272); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Skeletal muscle atrophy (HP:0003202)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 Patient 2 (FEMALE; P25Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Spastic gait (HP:0002064); Spastic paraplegia (HP:0001258); Lower limb muscle weakness (HP:0007340); Upper limb muscle weakness (HP:0003484); Skeletal muscle atrophy (HP:0003202); Impaired vibratory sensation (HP:0002495); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 Patient 3 (FEMALE; P25Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Spastic gait (HP:0002064); Spastic paraplegia (HP:0001258); Lower limb muscle weakness (HP:0007340); Upper limb muscle weakness (HP:0003484); Skeletal muscle atrophy (HP:0003202); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 Patient 4 (MALE; P50Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Spastic gait (HP:0002064); Spastic paraplegia (HP:0001258); Lower limb muscle weakness (HP:0007340); Upper limb muscle weakness (HP:0003484); Skeletal muscle atrophy (HP:0003202); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 3 Patient 5 (FEMALE; P17Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Ataxia (HP:0001251); Seizure (HP:0001250); Spastic paraplegia (HP:0001258); Lower limb muscle weakness (HP:0007340); Babinski sign (HP:0003487); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Cerebellar atrophy (HP:0001272); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249)</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 4 Patient 6 (MALE; P15Y)</td><td style=\"text-align: left;\">Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)</td><td style=\"text-align: left;\">NM_001130438.3:c.55C>T (heterozygous)</td><td style=\"text-align: left;\">Spastic gait (HP:0002064); Spastic paraplegia (HP:0001258); Lower limb muscle weakness (HP:0007340); Nystagmus (HP:0000639); excluded: Pes cavus (HP:0001761); excluded: Dystonia (HP:0001332); excluded: Ataxia (HP:0001251); excluded: Cerebellar atrophy (HP:0001272); excluded: Seizure (HP:0001250); excluded: Peripheral axonal neuropathy (HP:0003477); excluded: Microcephaly (HP:0000252); excluded: Intellectual disability (HP:0001249); excluded: Upper limb muscle weakness (HP:0003484); excluded: Skeletal muscle atrophy (HP:0003202)</td></tr>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table = IndividualTable(individuals)\n",
    "display(HTML(table.to_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "1c9f3cdd-7520-4348-87ed-df9305052dbe",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[pyphetools] Ingested 85 GA4GH phenopackets.\n",
      "[INFO] Extracted 28 from 85 phenopackets with OMIM:620538\n",
      "\n",
      "\tSpastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538): n=28\n",
      "We found a total of 25 unique HPO terms\n",
      "Extracted disease: Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia (OMIM:620538)\n",
      "Wrote HPOA disease file to OMIM-620538.tab\n"
     ]
    }
   ],
   "source": [
    "pmid = \"PMID:35150594\"\n",
    "df = timporter.create_hpoa_from_phenopackets(pmid=pmid, moi=\"Autosomal dominant\", target=\"OMIM:620538\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "94a895fc-8fa6-4311-aa86-8d4adbda386f",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
